“I’m optimistic about the future of self-care,” said PAGB president Neil Lister on the occasion of the association’s 100-year anniversary. “If we work together, we can support the cultural and behavioral change we need in our country to fully embed self-care in our everyday lives.”
At a gala event at London’s Science Museum to celebrate PAGB’s centenary, Lister told the assembled guests – drawn from manufacturers, regulators, industry groups, agencies and healthcare professionals – that collaboration would be key for the association to emulate the achievements of the past 100 years. “We can’t do this on our own,” he insisted. “We want to build on the partnership working that has been so important to us throughout our history.”
PAGB had “come a long way” since its founding in 1919 as the Association of the Manufacturers of British Proprietaries, Lister pointed out, embracing change and adopting new technologies. But there was “still a lot more to do,” he insisted.
“The industry has a big agenda,” Lister revealed, “including responding to the challenges of EU exit, maximizing the opportunities new digital technologies offer us, and addressing environmental concerns.” (Also see "AESGP Annual Meeting, Day 2: Grappling With Environmental Concerns, 'Nudging' Towards Self-Care Adoption, And Future Trends" - HBW Insight, 6 Jun, 2019.)
PAGB would continue to call for a national strategy for self-care, Lister noted, and to encourage government to implement policies which would “make it easier for people to take responsibility for their own health and well being.” (Also see "PAGB sets out self-care vision" - HBW Insight, 10 Aug, 2018.)
Pharmacy had a key role to play in this, he insisted, alongside other healthcare professionals.
“Most of all though,” Lister concluded, “as a responsible industry we want to continue to work closely with regulators to make sure people have access to effective products that they can use to self-care for themselves and their families.”
Lister thanked guests for supporting PAGB “then, now and for tomorrow.”
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: